Disease composition and medical expenses of chronic kidney disease in People's Hospital of Xinjiang Uygur Autonomous Region from 2012 to 2017: a cross-sectional survey_Chinese Journal of Evidence-Based Medicine

Authors：

ZHENG Xiao ¹ , ZHANG Jingjing ² ,  LU Chen ³

1. Xinjiang Clinical College of Anhui Medical University, Urumqi, 830001, P.R.China;
2. Shihezi University, Shihezi, 832000, P.R.China;
3. People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, P.R.China;

Corresponding author：

LU Chen, Email: luchen706@163.com

Keywords：

Chronic kidney disease; Inpatient; Disease composition; Medical expense

DOI：

10.7507/1672-2531.201802050

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To investigate the disease composition and medical costs of in patients with chronic kidney disease (CKD) in People's Hospital of Xinjiang Uygur Autonomous Region from 2012 to 2017. Methods To retrieve the records of patients with CKD, and to classify the main diagnosis of the first page of the medical record according to the International Classification of Diseases (ICD-10) standard. Data was analyzed using Excel 2010 and SPSS 19.0 software. Results A total of 11 650 CKD patients were included, with a sex ratio of 1.48 to 1. The patients were mainly young and middle-aged, accounting for 75.56%. The top 11 diseases of CKD patients were chronic glomerulonephritis, membranous nephropathy, diabetic nephropathy, IgA nephropathy, hypertensive nephropathy, minimally pathological nephritis, focal segmental glomerulosclerosis, lupus nephritis, Polycystic kidney disease, chronic interstitial nephritis and purpuric nephritis. The per capita hospitalization days of CKD patients was 11.23 days, and the per capita medical expenses was 1.51 million yuan. Significant differences were found in different genders, ethnic groups, age groups, disease composition and CKD staging. The medical expenses of CKD patients were mainly medicine and inspection fees, accounting for 71.35%. Conclusions Inpatients of CKD in the People's Hospital of Xinjiang Uygur Autonomous Region have a heavy disease burden and large difference in their conditions.

Citation： ZHENG Xiao, ZHANG Jingjing, LU Chen. Disease composition and medical expenses of chronic kidney disease in People's Hospital of Xinjiang Uygur Autonomous Region from 2012 to 2017: a cross-sectional survey. Chinese Journal of Evidence-Based Medicine, 2018, 18(9): 903-906. doi: 10.7507/1672-2531.201802050 Copy

1.	National Kidney Foundation. KDOQI clinical practice guide-line for diabetes and CKD: 2012 Update. Am J Kidney Dis, 2012, 60(5): 850.
2.	丁弘, 刘殿阁, 陈涵枝, 等. 567 例新发脑卒中慢肾性脏病流行病学特点. 临床荟萃, 2009, 24(22): 1945.
3.	Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012, 379(9818): 815-822.
4.	刘东伟. 慢性肾脏病流行病学和危险因素变迁及其系统评价. 郑州: 郑州大学, 2015.
5.	赵红娟, 陆晨, 岳华, 等. 乌鲁木齐市天山区 35 岁以上成人慢性肾脏病流行病学调查及相关因素分析. 中华肾脏病杂志, 2010, 26(6): 409-415.
6.	迪力木拉提, 李增录, 刘健, 等. 新疆墨玉县农村维吾尔族成人慢性肾脏病流行病学调查. 中华肾脏病杂志, 2009, 25(8): 607-612.
7.	乔勤, 顾波. 我国与全球终末期肾脏病的流行现状. 中国血液净化杂志, 2014, 13(10): 729-730.
8.	梁丽芬, 徐加, 段丽珍. 108 例慢性肾衰竭患者住院费用分析. 临床医药实践, 2016, 25(1): 60-62.
9.	宋慧, 谢修强, 居益君, 等. 对应分析在慢性肾脏病患者住院费用影响因素中的应用. 中国病案, 2017, 18(2): 59-62.
10.	莎仁娜, 王梅红, 桑晓红, 等. 1514 例成年慢性肾脏病住院患者病因与相关因素分析. 中国中西医结合肾病杂志, 2014, 15(9): 811-813.
11.	郑笑, 宋雪, 陆晨. 新疆某三甲医院肾病科住院患者的疾病构成. 中国病案, 2018, 19(5): 71-74.
12.	张文欣, 储敏. 2005 年-2014 年某医院肾内科住院患者疾病构成分析. 中国病案, 2017, 17(9): 75-78.
13.	龙俊睿, 单婵娟, 杨群娣, 等. 上海市某三甲医院 2011―2016 年慢性肾脏病住院患者调查分析. 第二军医大学学报, 2018, 39(1): 13-18.
14.	王祥, 张云香, 范小丽, 等. 潍坊市肾脏疾病病理类型分布的流行病学特点及疾病谱的演变. 中国全科医学, 2016, 19(B12): 307-311.
15.	Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis, 2012, 59(Suppl 1): A7, e1-420.
16.	梁雪, 刘庆婧, 陈康, 等. 2型糖尿病伴慢性肾脏病患者住院费用及用药分析. 中国慢性病预防与控制杂志, 2016, 24(7): 498-501.
17.	高莉, 周刚, 冯石献, 等. 河南省居民糖尿病流行特征调查. 郑州大学学报(医学版), 2014, 49(1): 123.
18.	李文, 芦文丽, 王媛, 等. 高血压患者血压控制情况及影响因素分析. 中国公共卫生, 2012, 28(2): 154.
19.	黎夏, 魏登军. 慢性肾病患者住院医疗费用负担分析. 公共卫生与预防医学, 2015, 26(6): 64-67.
20.	龙俊睿, 单婵娟, 王九生, 等. 上海市某三甲医院慢性肾脏病住院患者床日住院费用时间序列分析. 第二军医大学学报, 2018, 39(1): 29-36.

1. National Kidney Foundation. KDOQI clinical practice guide-line for diabetes and CKD: 2012 Update. Am J Kidney Dis, 2012, 60(5): 850.
2. 丁弘, 刘殿阁, 陈涵枝, 等. 567 例新发脑卒中慢肾性脏病流行病学特点. 临床荟萃, 2009, 24(22): 1945.
3. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012, 379(9818): 815-822.
4. 刘东伟. 慢性肾脏病流行病学和危险因素变迁及其系统评价. 郑州: 郑州大学, 2015.
5. 赵红娟, 陆晨, 岳华, 等. 乌鲁木齐市天山区 35 岁以上成人慢性肾脏病流行病学调查及相关因素分析. 中华肾脏病杂志, 2010, 26(6): 409-415.
6. 迪力木拉提, 李增录, 刘健, 等. 新疆墨玉县农村维吾尔族成人慢性肾脏病流行病学调查. 中华肾脏病杂志, 2009, 25(8): 607-612.
7. 乔勤, 顾波. 我国与全球终末期肾脏病的流行现状. 中国血液净化杂志, 2014, 13(10): 729-730.
8. 梁丽芬, 徐加, 段丽珍. 108 例慢性肾衰竭患者住院费用分析. 临床医药实践, 2016, 25(1): 60-62.
9. 宋慧, 谢修强, 居益君, 等. 对应分析在慢性肾脏病患者住院费用影响因素中的应用. 中国病案, 2017, 18(2): 59-62.
10. 莎仁娜, 王梅红, 桑晓红, 等. 1514 例成年慢性肾脏病住院患者病因与相关因素分析. 中国中西医结合肾病杂志, 2014, 15(9): 811-813.
11. 郑笑, 宋雪, 陆晨. 新疆某三甲医院肾病科住院患者的疾病构成. 中国病案, 2018, 19(5): 71-74.
12. 张文欣, 储敏. 2005 年-2014 年某医院肾内科住院患者疾病构成分析. 中国病案, 2017, 17(9): 75-78.
13. 龙俊睿, 单婵娟, 杨群娣, 等. 上海市某三甲医院 2011―2016 年慢性肾脏病住院患者调查分析. 第二军医大学学报, 2018, 39(1): 13-18.
14. 王祥, 张云香, 范小丽, 等. 潍坊市肾脏疾病病理类型分布的流行病学特点及疾病谱的演变. 中国全科医学, 2016, 19(B12): 307-311.
15. Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis, 2012, 59(Suppl 1): A7, e1-420.
16. 梁雪, 刘庆婧, 陈康, 等. 2型糖尿病伴慢性肾脏病患者住院费用及用药分析. 中国慢性病预防与控制杂志, 2016, 24(7): 498-501.
17. 高莉, 周刚, 冯石献, 等. 河南省居民糖尿病流行特征调查. 郑州大学学报(医学版), 2014, 49(1): 123.
18. 李文, 芦文丽, 王媛, 等. 高血压患者血压控制情况及影响因素分析. 中国公共卫生, 2012, 28(2): 154.
19. 黎夏, 魏登军. 慢性肾病患者住院医疗费用负担分析. 公共卫生与预防医学, 2015, 26(6): 64-67.
20. 龙俊睿, 单婵娟, 王九生, 等. 上海市某三甲医院慢性肾脏病住院患者床日住院费用时间序列分析. 第二军医大学学报, 2018, 39(1): 29-36.

Journal type citation(11)

1.	张军. 伊伐布雷定联合沙库巴曲缬沙坦治疗低血压状态下HFrEF患者的效果观察. 中国现代药物应用. 2024(02): 90-93 . Baidu Scholar
2.	欧阳嘉慧，张淼，杜天依，高铸烨，李立志. 中药联合伊伐布雷定治疗慢性心力衰竭的Meta分析. 海南医学院学报. 2023(09): 703-709 . Baidu Scholar
3.	陈静，成华，刘洋，孙文芳，庞晶瑶，刘宪军. 盐酸伊伐布雷定治疗心力衰竭的快速卫生技术评估. 中国医院用药评价与分析. 2022(02): 213-216+223 . Baidu Scholar
4.	张颖，王敏，徐凌忠. 伊伐布雷定治疗慢性心力衰竭的效果观察. 中国医学创新. 2022(16): 40-44 . Baidu Scholar
5.	刘性涛. 伊伐布雷定治疗老年心力衰竭的效果及安全性评价. 中国实用医刊. 2022(08): 101-105 . Baidu Scholar
6.	张春莹，白志生，吕永会，王露. 伊伐布雷定联合沙库巴曲缬沙坦治疗低血压状态HFrEF疗效观察. 海南医学. 2022(23): 3013-3016 . Baidu Scholar
7.	何海潇. 慢性心力衰竭的药物治疗进展. 中国城乡企业卫生. 2021(04): 43-45 . Baidu Scholar
8.	欧明春，朱洁云，吉攀，李红园，何翠影，张剑锋，庞杰龙. 艾司洛尔治疗脓毒性休克有效性及安全性的Meta分析. 检验医学与临床. 2021(08): 1029-1034 . Baidu Scholar
9.	李琚平，管文娟，黄占宏. 伊伐布雷定联合常规抗心力衰竭治疗老年心力衰竭的疗效及对心率变异性的影响. 中国实用医刊. 2021(20): 96-99 . Baidu Scholar
10.	边亚男，张婷. N端B型脑钠肽前体对慢性心力衰竭患者心功能预测价值研究. 临床军医杂志. 2020(03): 338-339 . Baidu Scholar
11.	赵国强. 伊伐布雷定联合重组人脑利钠肽治疗慢性心力衰竭的临床效果观察. 中国实用医药. 2020(25): 112-114 . Baidu Scholar

Other types of references(11)

1.	胡兴茂. 注射用益气复脉（冻干）对比心脉隆注射液治疗慢性心力衰竭的药物经济学评价[D]. 河北医科大学. 2020. Baidu Scholar
2.	丁丹丹. 心力康丸治疗慢性心力衰竭临床疗效观察[D]. 湖北中医药大学. 2020. Baidu Scholar
3.	熊芳蕾. 166例心力衰竭患者发病及中医证治规律的回顾性分析[D]. 黑龙江中医药大学. 2020. Baidu Scholar
4.	沈梦姣. 伊伐布雷定联合达格列净对慢性心力衰竭患者短期炎症因子和无创血流动力学等相关指标的观察[D]. 苏州大学. 2022. Baidu Scholar
5.	谷思洁. 益气通痹汤治疗风湿性心脏病合并心力衰竭气虚血瘀证的临床观察[D]. 湖南中医药大学. 2021. Baidu Scholar
6.	赵阳. 参芪丹鸡黄精汤治疗射血分数降低的慢性心衰（气虚血瘀证）的疗效观察[D]. 华北理工大学. 2022. Baidu Scholar
7.	谭楠楠. 慢性心力衰竭气虚证相关理化指标及尿液代谢组学研究[D]. 北京中医药大学. 2021. Baidu Scholar
8.	扎伊代·阿卜杜艾尼. 宝心蚕茧口服液治疗慢性心力衰竭的临床研究[D]. 新疆医科大学. 2023. Baidu Scholar
9.	施俊峰. 参芪健心方治疗气虚血瘀证慢性心力衰竭患者的临床观察[D]. 安徽中医药大学. 2020. Baidu Scholar
10.	熊芊卉. 伊伐布雷定在急性心衰中运用的有效性及安全性RCT试验的meta分析[D]. 南昌大学. 2022. Baidu Scholar
11.	杜昌鹏. 附萸镇心汤治疗慢性心衰（阳虚血瘀水结证）的临床研究[D]. 长春中医药大学. 2022. Baidu Scholar

Previous Article
Cancer incidence and mortality in Henan province: report of cancer registries in 2014 GUOLanwei, LIU Shuzheng, CAO Xiaoqin, CHEN Qiong, ZHANG Shaokai, ZHANG Meng, YU Da, QUAN Peiliang, SUN Xibin
Next Article
The application value of 6-minute walking test in clinical evaluation of chronic heart failure HOUYazhu, YAN Lingyan, MAO Jingyuan, WANG Xianliang, LI Ling, ZHONG Chengliang, LIU Hanwen, ZHAO Zhiqiang

Chinese Journal of Evidence-Based Medicine

Disease composition and medical expenses of chronic kidney disease in People's Hospital of Xinjiang Uygur Autonomous Region from 2012 to 2017: a cross-sectional survey

Abstract Full text Figures/Tables Video References Cited by

Journal type citation(11)

Other types of references(11)

Previous Article

Next Article

Format

Content